Abbott Laboratories: Buy The Dip On This Dividend King [Seeking Alpha]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Seeking Alpha
ABT's diversified healthcare platform is reshaping toward higher-growth areas, highlighted by the Exact Sciences acquisition, expected to add $3B in sales this year. Medical devices and pharmaceuticals segments continue to deliver above-market growth, while the dividend remains well-covered, with a 2.6% yield and 8.5% 5-year CAGR. Trading at a forward P/E of 17.7, below its historical average, ABT offers mid-teens total return potential, as valuation normalizes and growth accelerates in H2 and beyond. Looking for a portfolio of ideas like this one? Members of iREIT®+HOYA Capital get exclusive access to our subscriber-only portfolios. Learn More » MicroStockHub/iStock via Getty Images There are few names in healthcare that combine durability, innovation, and income quite like Abbott Laboratories ( ABT ). Yet ,even the strongest operators hit periods where sentiment softens and expectations reset. That's where opportunity tends to show up. After a modest More on my IG ser
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (ABT) had its price target lowered by UBS Group AG from $158.00 to $135.00. They now have a "buy" rating on the stock.MarketBeat
- Abbott Laboratories (ABT) had its price target lowered by Argus from $140.00 to $125.00. They now have a "buy" rating on the stock.MarketBeat
- Abbott Laboratories (ABT) had its price target lowered by Leerink Partners from $119.00 to $106.00. They now have a "market perform" rating on the stock.MarketBeat
- Abbott's CancerGuard Progress Adds New Dimension To Diagnostics Growth Story [Yahoo! Finance]Yahoo! Finance
- Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 4/17/26 - Form 8-K
- 4/16/26 - Form 8-K
- 4/2/26 - Form 4
- ABT's page on the SEC website